Person-Centered Care Approaches to the Treatment of Patients With Neuropsychiatric Manifestations of Parkinson’s Disease (CME/CE Podcast)

Activity Description and Purpose

Dr Agronin is a leading expert on psychiatric manifestations of Parkinson’s disease. In this podcast, he talks about diagnostic strategies, behavioral measures, and the pharmacologic treatment of Parkinson’s disease psychosis. Along the way, he shares insights from his decades in clinical practice and practical guidelines for caregivers facing this challenging disease. The desired results of this activity are for psychiatric clinicians to understand the treatments available and develop evidence-based treatment plans for complex patients who suffer from psychosis, dementia, depression, apathy, and/or anxiety while maintaining the safety and quality of life of patients

Target Audience

This educational activity is intended for psychiatric clinicians, including physicians, physician assistants, nurse practitioners, and nurses, caring for patients with Parkinson’s disease.

Learning Objectives

After completing this activity, participants will be better able to:

  • Describe the use of behavioral management strategies to manage neuropsychiatric aspects of Parkinson’s disease
  • Develop evidence-based treatment strategies for patients with Parkinson’s disease and comorbid neuropsychiatric conditions (eg, Parkinson’s disease psychosis, Parkinson’s disease dementia, depression, anxiety, and agitation)
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 Participation
Course opens: 
Course expires: 


Marc E. Agronin, MD
Chief Medical Officer for MIND Institute and Behavioral Health
Miami Jewish Health
Miami, Florida

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.


Marc E. Agronin, MD, is an advisory board member of Corium, Inc, and Genentech, Inc; and is a contracted researcher for Alzheon, Inc, Avanir Pharmaceuticals, Inc, Cerevel Therapeutics, Eisai Inc, Eli Lilly and Company, Janssen Pharmaceuticals, Inc, Karuna Therapeutics, Suven Neurosciences, Inc, and T3D Therapeutics.

Peer Reviewers

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Interviewers, Planners, Managers, and Writers

Fabian Bresan, MD, MedEdicus Interviewer for this activity, has no relevant commercial relationships to disclose.

Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.

Other MedEdicus and Amedco planners, managers, and writers have no relevant commercial relationships to disclose.

Satisfactory Completion 

Learners must listen to each self-directed audio recording while following along with the podcast and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be viewed in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

For Physicians

ACCME Accreditation Statement

MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit Designation Statement

MedEdicus LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses

Interprofessional Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 0.5 ANCC contact hour.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at


The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or ACADIA Pharmaceuticals Inc.

©2023 MedEdicus LLC. 292.1

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 Participation
Please login or register to take this course.

Clicking Register/Take course indicates that you have reviewed the CME/CE information for this activity.